Market News
Stay updated with the latest market trends, earnings, and economic indicators.
MSME Minister Jitan Ram Manjhi reviews flagship schemes in Puducherry, stresses technology, credit, skills and market access
The Minister urged banks to facilitate greater access to institutional credit for MSMEs and called upon all stakeholders to ensure effective implementation of Government initiatives for the growth of the sector. On 8 July 2026, he visited the MSME Technology Centre, Puducherry and reviewed the Centre's training and production facilities. The Minister interacted with trainees undergoing technology-driven skill development programmes and inspected products manufactured using advanced machinery. He emphasised that equipping youth with modern technology-driven skills and making them self-reliant and employment-ready is a key priority of the Ministry. He noted that MSME Technology Centres are playing a vital role in developing a skilled workforce, strengthening the manufacturing ecosystem and supporting the vision of Atmanirbhar Bharat and Viksit Bharat.
FirstCry-promoted Swara Baby Products files draft papers for ₹1,000-cr IPO
Swara Baby Products, a contract manufacturer of baby diapers, adult diapers and feminine hygiene products backed by FirstCry, on Thursday filed draft papers with markets regulator Sebi to raise Rs 1,000 crore through an initial public offering (IPO). The proposed IPO comprises a fresh issue of equity shares aggregating up to Rs 500 crore and an offer for sale (OFS) valued at Rs 500 crore by promoters, according to the draft red herring prospectus (DRHP). The OFS includes sale of shares worth up to Rs 300 crore by Brainbees Solutions Ltd, the parent company of FirstCry, and up to Rs 200 crore by Anadya Bon Merchari LLP. The company proposes to utilise the net proceeds from the fresh issue to set up a new manufacturing facility in Madhya Pradesh with an allocation of Rs 198.2 crore, repay or prepay loans amounting to Rs 100 crore, and invest Rs 27.5 crore in subsidiaries Solis Hygiene, Swara Hygiene and K.A. Enterprises Hygiene Pvt Ltd (KAEHPL) for repayment of their outstanding ...
eSARAS Empowers Women-Led Self-Help Groups by Connecting Rural Artisans to National Markets and Driving Inclusive Digital Growth
eSARAS is the official online marketplace of DAY-NRLM, built exclusively for products made by women Self-Help Groups and their federations. The well curated handrafted goods emerge from the very heart of the country- from weavers in Chanderi sarees from Madhya Pradesh to marble artisans in Rajasthan. They also include Pashmina producers nestled in the hills of Jammu & Kashmir. Every product on eSARAS carries a story, and every purchase is a direct connection to the artisan behind it.
BPCL to buy 40% stake in Shell, Tiki Tar venture to expand value-added bitumen business
Bharat Petroleum Corporation Ltd. is acquiring a 40% stake in Tiki Tar and Shell India for Rs 85 crore, marking its significant entry into India's booming value-added bitumen market. This strategic move aims to capitalize on the nation's infrastructure development, particularly road construction. The joint venture will leverage Shell's technology and Tiki Tar's manufacturing capabilities, combined with BPCL's extensive distribution network, to supply advanced bitumen products for major projects.
Bharat Petroleum Corporation inks deal to acquire 40% stake in Tiki Tar and Shell India
TTSIPL operates in the business of marketing, processing, purchasing, importing, exporting, and selling bitumen and bituminous products primarily in India, with export sales extending to Nepal, Bhutan, and Bangladesh. Its product portfolio provides solutions for both highways and airport runways, consisting specifically of VG Grade Bitumen, Polymer Modified Bitumen (PMB), Crumb Rubber Modified Bitumen (CRMB), Emulsion, and Emulsion OB.
BPCL to buy 40% stake in Tiki Tar and Shell India for Rs 85 crore
Bharat Petroleum Corporation is set to acquire a 40% stake in Tiki Tar and Shell India for Rs 85 crore, bolstering its presence in India's expanding value-added bitumen market. This strategic move, approved by DIPAM, aims to capitalize on the nation's infrastructure growth. Tiki Tar and Shell India, a manufacturer and marketer of specialized bitumen products, also exports to neighboring countries.
Stocks to buy: Tech analyst picks Astra Microwave, Jay Bharat, Welspun Corp
Stocks to Buy: Choice Broking Weekly Recommendations, Aakash Shah recommends buy on Welspun Corp, Astra Microwave Products and Jay Bharat Maruti.
Dalmia Bharat plans to raise Rs 4,000 cr; targets 110-130 MTPA cement capacity by FY31
Dalmia Bharat is set to raise up to Rs 4,000 crore to fuel its ambitious expansion, aiming to reach 110-130 million tonnes per annum cement capacity by FY31. This strategic move, involving acquisitions and organic growth, aligns with anticipated industry demand driven by infrastructure and housing. The company is also focusing on premium products and strengthening its pan-India presence, building on recent acquisitions and strong financial performance.

Paras Defence, MTAR Tech, HAL Shares Rally In Trade As India's Defence Production Touches All-Time High
Paras Defence emerged as the top gainer, surging 12.89%, followed by Astra Microwave Products, which advanced 7.72%, and MTAR Technologies, up 6.99%. Data Patterns gained 4.81%, while Bharat Dynamics rose 4.39%.
Hindustan Zinc signs pact with Sulfozyme Agro to advance sustainable metal recovery
Hindustan Zinc has partnered with Sulfozyme Agro India. This collaboration aims to boost sustainable metal recovery. Sulfozyme Agro will operate at Hindustan Zinc's Zinc Industrial Park. They will process zinc materials into value-added products. Hindustan Zinc will provide raw material support. This initiative strengthens the MSME ecosystem in Rajasthan. It promotes industrial growth and entrepreneurship.

Ola Electric Plans Full Transition To In-House Battery Cells By Sept 2026: Bhavish Aggarwal To Shareholders
Ola Electric said around 15% of current orders are already coming from products powered by its own 4680 Bharat Cells.
Mankind Pharma profit jumps 30% on chronic therapy demand in Q4
Mankind Pharma announced a significant 30 percent profit increase for the fourth quarter. This growth was fueled by strong demand for chronic therapies and consumer healthcare products. The company's domestic formulations business is showing a revival. Improved sales execution and the successful integration of Bharat Serums and Vaccines contributed to this positive performance.